Stockscreener 앱 받기
5.61
2.56%
0.14
시간 외 거래:
5.60
-0.01
-0.18%
전일 마감가:
$5.47
열려 있는:
$5.54
하루 거래량:
3.92M
Relative Volume:
0.92
시가총액:
$549.71M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+4.28%
1개월 성능:
+7.47%
6개월 성능:
+78.10%
1년 성능:
+220.57%
1일 변동 폭
$5.27
$5.63
1주일 범위
$5.2303
$6.08
52주 변동 폭
$1.67
$7.2904
Atyr Pharma Inc Stock (ATYR) Company Profile
명칭
Atyr Pharma Inc
전화
(858) 731-8389
주소
10240 SORRENTO VALLEY ROAD, SAN DIEGO
ATYR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATYR
Atyr Pharma Inc
|
5.61 | 535.99M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Atyr Pharma Inc Stock (ATYR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-18 | 개시 | Leerink Partners | Outperform |
| 2025-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-10-04 | 개시 | Wells Fargo | Overweight |
| 2024-09-05 | 개시 | Jefferies | Buy |
| 2023-07-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-10-12 | 개시 | RBC Capital Mkts | Outperform |
| 2021-09-21 | 개시 | Piper Sandler | Overweight |
| 2021-05-10 | 개시 | Laidlaw | Buy |
| 2020-08-17 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | 개시 | ROTH Capital | Buy |
| 2020-03-02 | 개시 | Oppenheimer | Outperform |
| 2018-02-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-09-07 | 개시 | Piper Jaffray | Overweight |
| 2016-12-13 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2015-12-16 | 개시 | Citigroup | Neutral |
| 2015-06-01 | 개시 | Citigroup | Buy |
| 2015-06-01 | 개시 | JP Morgan | Overweight |
모두보기
Atyr Pharma Inc 주식(ATYR)의 최신 뉴스
Multi asset correlation models including aTyr Pharma Inc.Weekly Risk Summary & Growth Focused Stock Reports - Newser
When is the best time to exit aTyr Pharma Inc.July 2025 News Drivers & Consistent Growth Stock Picks - Newser
How a Surge in Bearish Options Activity at aTyr Pharma (ATYR) Has Changed Its Investment Story - simplywall.st
aTyr Pharma Inc. stock daily chart insightsWeekly Trend Summary & Entry Point Confirmation Signals - Newser
Is aTyr Pharma Inc. a play on infrastructure spendingJuly 2025 Outlook & Fast Moving Stock Trade Plans - خودرو بانک
Is aTyr Pharma Inc. forming bullish engulfing patternsMarket Sentiment Review & Precise Trade Entry Recommendations - خودرو بانک
What is aTyr Pharma Inc.’s book value per shareQuarterly Trade Report & Fast Momentum Stock Entry Tips - خودرو بانک
Using AI based signals to follow aTyr Pharma Inc.Global Markets & High Accuracy Swing Entry Alerts - Newser
Published on: 2025-09-06 02:07:40 - خودرو بانک
ATyr Pharma's Strategic Talent Retention and Pipeline Momentum Signal Long-Term Value Creation - AInvest
ATyr Pharma announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ATYR Stock News - GuruFocus
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biotech aTyr Pharma Awards 62,400 Shares to New Employees for Novel tRNA Drug Development Program - Stock Titan
Is aTyr Pharma Inc.’s ROE strong enough2025 Market WrapUp & Safe Entry Trade Reports - خودرو بانک
Can aTyr Pharma Inc. rally from current levels2025 Key Highlights & Weekly High Return Opportunities - Newser
Tick level data insight on aTyr Pharma Inc. volatility2025 Trade Ideas & Real-Time Chart Breakout Alerts - Newser
Block Trades: Is aTyr Pharma Inc. exposed to political riskJuly 2025 Snapshot & Weekly Stock Performance Updates - خودرو بانک
What data driven models say about aTyr Pharma Inc.’s futureProfit Target & Fast Moving Trade Plans - Newser
Visualizing aTyr Pharma Inc. stock with heatmaps2025 Top Decliners & Safe Capital Growth Tips - Newser
Using fundamentals and technicals on aTyr Pharma Inc.Portfolio Value Report & Weekly Momentum Picks - Newser
aTyr Pharma Inc.’s volatility index tracking explainedWeekly Trend Summary & Real-Time Stock Movement Alerts - Newser
Will breakout in aTyr Pharma Inc. lead to full recoveryJuly 2025 Setups & Safe Capital Growth Stock Tips - Newser
aTyr Pharma’s Sharp Intraday Drop: What’s Behind the Move? - AInvest
aTyr Pharma Inc put volume heavy and directionally bearish - TipRanks
Volatility clustering patterns for aTyr Pharma Inc.July 2025 PreEarnings & AI Enhanced Trade Execution Alerts - Newser
Does aTyr Pharma Inc. qualify in momentum factor screeningJuly 2025 Movers & Daily Risk Controlled Trade Plans - Newser
Heatmap analysis for aTyr Pharma Inc. and competitors2025 Risk Factors & Long-Term Growth Portfolio Plans - Newser
Aug Rallies: Is aTyr Pharma Inc.’s ROE strong enoughInsider Buying & Community Verified Trade Signals - خودرو بانک
Is aTyr Pharma Inc. exposed to political riskMarket Risk Report & Daily Growth Stock Investment Tips - خودرو بانک
aTyr Pharma Inc. recovery potential after sell off2025 Trade Ideas & Stepwise Trade Signal Implementation - Newser
Multi factor analysis applied to aTyr Pharma Inc.2025 Short Interest & Community Consensus Picks - Newser
Bank Watch: Is aTyr Pharma Inc. stock heavily shortedJuly 2025 Setups & Real-Time Volume Analysis Alerts - خودرو بانک
Risk adjusted return profile for aTyr Pharma Inc. analyzed2025 Analyst Calls & Entry Point Strategy Guides - Newser
Top chart patterns to watch in aTyr Pharma Inc.Trade Performance Summary & Low Risk Investment Opportunities - Newser
How to build a custom watchlist for aTyr Pharma Inc.Wall Street Watch & Low Drawdown Investment Ideas - Newser
Regression analysis insights on aTyr Pharma Inc. performanceM&A Rumor & High Accuracy Swing Trade Signals - Newser
Developing predictive dashboards with aTyr Pharma Inc. dataTrade Exit Summary & Verified Chart Pattern Trade Signals - Newser
Is aTyr Pharma Inc. stock forming a triangle patternEarnings Performance Report & Technical Pattern Based Signals - خودرو بانک
Risk Hedge: Is aTyr Pharma Inc. stock heavily shortedWall Street Watch & Smart Allocation Stock Tips - خودرو بانک
How to track smart money flows in aTyr Pharma Inc.2025 AllTime Highs & Free Reliable Trade Execution Plans - Newser
Price momentum metrics for aTyr Pharma Inc. explainedJuly 2025 Recap & Expert Curated Trade Ideas - Newser
What’s the analyst consensus on aTyr Pharma Inc.Weekly Profit Report & Risk Controlled Swing Alerts - خودرو بانک
Technical analysis overview for aTyr Pharma Inc. stockJuly 2025 Institutional & High Accuracy Buy Signal Tips - Newser
Can aTyr Pharma Inc. grow without external fundingJuly 2025 Momentum & Breakout Confirmation Trade Signals - خودرو بانک
ATYR.O (aTyr Pharma) Surges 11.83% Intraday: What’s Driving the Move? - AInvest
Atyr Pharma Inc (ATYR) 재무 분석
Atyr Pharma Inc (ATYR)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):